drugset / Trial / NCT05515185
B7-H3 Targeting CAR-T Cells Therapy for B7-H3 Positive Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is a clinical study to evaluate the safety and efficacy of CAR-T cells in the treatment of patients with advanced solid tumors in China.
Timeline
- Start
- 2022-09-09
- Primary completion
- 2024-09-08
- Completion
- 2024-09-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KT095 CAR-T | Cell therapy | — | Intravenous |
| Background | Cyclophosphamide | Other / unclassified | — | — |
| Background | Fludarabine | Small molecule | — | — |